| Disease burden due to enterotoxigenic Escherichia coli in the first 2 years of life in an urban community in Bangladesh F Qadri, A Saha, T Ahmed, A Al Tarique, YA Begum, AM Svennerholm Infection and immunity 75 (8), 3961-3968, 2007 | 241 | 2007 |
| Association of Enterotoxigenic Bacteroides fragilis Infection with Inflammatory Diarrhea CL Sears, S Islam, A Saha, M Arjumand, NH Alam, ASG Faruque, ... Clinical Infectious Diseases 47 (6), 797-803, 2008 | 180 | 2008 |
| Efficacy of a single-dose, inactivated oral cholera vaccine in Bangladesh F Qadri, TF Wierzba, M Ali, F Chowdhury, AI Khan, A Saha, IA Khan, ... New England Journal of Medicine 374 (18), 1723-1732, 2016 | 170 | 2016 |
| Feasibility and effectiveness of oral cholera vaccine in an urban endemic setting in Bangladesh: a cluster randomised open-label trial F Qadri, M Ali, F Chowdhury, AI Khan, A Saha, IA Khan, YA Begum, ... The Lancet 386 (10001), 1362-1371, 2015 | 148 | 2015 |
| Peru-15, a live attenuated oral cholera vaccine, is safe and immunogenic in Bangladeshi toddlers and infants F Qadri, MI Chowdhury, SM Faruque, MA Salam, T Ahmed, YA Begum, ... Vaccine 25 (2), 231-238, 2007 | 125 | 2007 |
| Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year of age A Saha, MI Chowdhury, F Khanam, MS Bhuiyan, F Chowdhury, AI Khan, ... Vaccine 29 (46), 8285-8292, 2011 | 118 | 2011 |
| Zinc Influences Innate Immune Responses in Children with Enterotoxigenic Escherichia coli-Induced Diarrhea A Sheikh, S Shamsuzzaman, SM Ahmad, D Nasrin, S Nahar, MM Alam, ... The Journal of nutrition 140 (5), 1049-1056, 2010 | 106 | 2010 |
| Diarrheal illness and healthcare seeking behavior among a population at high risk for diarrhea in Dhaka, Bangladesh F Chowdhury, IA Khan, S Patel, AU Siddiq, NC Saha, AI Khan, A Saha, ... PLoS One 10 (6), e0130105, 2015 | 103 | 2015 |
| Knowledge of, attitudes toward, and preventive practices relating to cholera and oral cholera vaccine among urban high-risk groups: findings of a cross-sectional study in Dhaka … T Wahed, SST Kaukab, NC Saha, IA Khan, F Khanam, F Chowdhury, ... BMC public health 13 (1), 242, 2013 | 98 | 2013 |
| Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh F Qadri, MI Chowdhury, SM Faruque, MA Salam, T Ahmed, YA Begum, ... The Journal of infectious diseases 192 (4), 573-579, 2005 | 92 | 2005 |
| Efficacy of a single-dose regimen of inactivated whole-cell oral cholera vaccine: results from 2 years of follow-up of a randomised trial F Qadri, M Ali, J Lynch, F Chowdhury, AI Khan, TF Wierzba, JL Excler, ... The Lancet Infectious Diseases 18 (6), 666-674, 2018 | 81 | 2018 |
| Coverage and cost of a large oral cholera vaccination program in a high-risk cholera endemic urban population in Dhaka, Bangladesh IA Khan, A Saha, F Chowdhury, AI Khan, MJ Uddin, YA Begum, BK Riaz, ... Vaccine 31 (51), 6058-6064, 2013 | 78 | 2013 |
| Infection by Helicobacter pylori in Bangladeshi children from birth to two years: relation to blood group, nutritional status, and seasonality TR Bhuiyan, F Qadri, A Saha, AM Svennerholm The Pediatric infectious disease journal 28 (2), 79-85, 2009 | 71 | 2009 |
| Salmonella enterica serovar Typhi-specific immunoglobulin A antibody responses in plasma and antibody in lymphocyte supernatant specimens in Bangladeshi patients with suspected … A Sheikh, MS Bhuiyan, F Khanam, F Chowdhury, A Saha, D Ahmed, ... Clinical and vaccine immunology 16 (11), 1587-1594, 2009 | 70 | 2009 |
| Evaluation of a probiotics, Bifidobacterium breve BBG-01, for enhancement of immunogenicity of an oral inactivated cholera vaccine and safety: a randomized, double-blind … F Matsuda, MI Chowdhury, A Saha, T Asahara, K Nomoto, AA Tarique, ... Vaccine 29 (10), 1855-1858, 2011 | 67 | 2011 |
| Cost of illness for cholera in a high risk urban area in Bangladesh: an analysis from household perspective AR Sarker, Z Islam, IA Khan, A Saha, F Chowdhury, AI Khan, F Qadri, ... BMC infectious diseases 13 (1), 518, 2013 | 64 | 2013 |
| Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh DT Leung, MA Rahman, M Mohasin, SM Patel, A Aktar, F Khanam, ... Clinical and vaccine immunology 19 (5), 690-698, 2012 | 55 | 2012 |
| Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti RC Charles, IJ Hilaire, LM Mayo-Smith, JE Teng, JG Jerome, MF Franke, ... PLoS Negl Trop Dis 8 (5), e2828, 2014 | 54 | 2014 |
| Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally … M Arifuzzaman, R Rashu, DT Leung, MI Hosen, TR Bhuiyan, MS Bhuiyan, ... Clinical and Vaccine Immunology 19 (8), 1304-1311, 2012 | 50 | 2012 |
| The oral cholera vaccine Shanchol™ when stored at elevated temperatures maintains the safety and immunogenicity profile in Bangladeshi participants A Saha, A Khan, U Salma, N Jahan, TR Bhuiyan, F Chowdhury, AI Khan, ... Vaccine 34 (13), 1551-1558, 2016 | 43 | 2016 |
